Benign Prostatic Hyperplasia

BackgrounD
Benign Prostatic Hyperplasia (BPH) is one of the most common benign disease in men that can lead to prostatic enlargement, prostatic obstruction and/or lower urinary tract symptoms. Pathologic changes are found in 88% of men aged 80 years or older and lower urinary tract symptoms reported in almost 50% of men aged 50 years or older in the general population.
The etiology is multi-factorial with age, PSA and prostate volume being the true factors related to the development of the disease. A group of patients at increased risk of progression can be identified based on these specific risk factors. For those, it might be appropriate to initiate early treatment. However, for some other patients, surgical treatment may be the best option.
Recent advances in screening and treatment are now available for management of patients in the Philippine setting. Clinical practice guidelines of the European Association of Urology and the American Urological Association were reviewed and modified to fit the needs of our local areas. Though mostly based on scientific evidence from literature, opinion of the majority of the Committee is given credibility since these urologists are the ones exposed to the patients at the grassroots level. Consideration is also given to the economic and legal factors in doing these guidelines. Caution is advised in using these guideline and no physician can be held liable for diverting from the following protocol. ( 
Surgery
The patient may appropriately select a surgical intervention as his initial treatment if he has bothersome symptoms.
Patients who have developed complications of BPH are best treated surgically (see table) The choices of surgical approach (open or endoscopic) and energy source (electrocautery vs laser) are technical decisions based on the patient's prostate size, the individual surgeon's judgment and the patient's comorbidities.
1 other technologies noT recommenDeD
• Prostatic stents are associated with significant complications such as encrustation, infection and chronic pain.
• Balloon dilatation is not recommended for patients with symptoms of BPH.
• 
